Intimation for Re-appointment of Cost Auditor and Appointment of Internal Auditor is attached herewith
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gufic Biosciences' Board of Directors, meeting on May 29, 2026, approved two items: (1) Re-appointment of M/s. Poddar & Co., Cost Accountants as Cost Auditors for Financial Year 2026-27, a firm with 15 years of experience led by Sandeep Poddar serving multiple sectors including Pharmaceuticals; (2) Appointment of Mrs. Saroj R. Kirdolia as Internal Auditor from FY 2026-27, who is a Chartered Accountant with 7 years of experience and has been with the company for 6 years, responsible for evaluating internal controls and business processes. The Board meeting lasted from 7:30 PM to 9:05 PM. Both appointments were disclosed under SEBI Listing Regulations, Regulation 30 and Part A of Schedule III.
These are routine governance appointments with no material impact on shareholding or leadership. The reappointment of Poddar & Co. ensures continuity in statutory cost audit compliance, while the appointment of an experienced internal auditor supports stronger internal controls and risk management.